Gut Peptide Hormone Levels Change Dramatically During Acute Hepatitis

Patients with acute viral hepatitis show significantly altered plasma levels of multiple gastrointestinal peptide hormones, which return to normal during liver regeneration.

Budillon, G et al.·The Italian journal of gastroenterology·1996·Preliminary EvidenceCross-Sectional
RPEP-00356Cross SectionalPreliminary Evidence1996RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Cross-Sectional
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Multiple gastrointestinal peptide hormone levels were significantly altered during acute hepatic cytonecrosis and returned toward normal during liver regeneration.

Key Numbers

How They Did This

Cross-sectional study measuring plasma gastrointestinal peptide hormone concentrations in 10 patients with acute viral hepatitis (8 hepatitis A, 2 hepatitis B) during acute illness and recovery.

Why This Research Matters

This study reveals the liver's role as a key regulator of gut peptide hormones, explaining why liver disease causes digestive symptoms and suggesting peptide hormone monitoring could track liver recovery.

The Bigger Picture

The gut-liver axis involves extensive peptide hormone signaling. Understanding how liver disease disrupts this system has implications for managing GI symptoms in liver disease patients.

What This Study Doesn't Tell Us

Small sample size (10 patients). Mixed hepatitis types (A and B). Cross-sectional design limits causal inference. Specific peptide hormones measured not detailed in abstract.

Questions This Raises

  • ?Could gut peptide hormone levels serve as biomarkers for liver function and recovery?
  • ?Do chronic liver diseases show similar peptide hormone disruptions?

Trust & Context

Key Stat:
Peptide levels normalize with recovery Altered GI peptide hormone levels during acute hepatitis returned toward normal as the liver regenerated
Evidence Grade:
Preliminary human evidence from a small cross-sectional study. Demonstrates the phenomenon but cannot establish causation.
Study Age:
Published in 1996, this study contributed to early understanding of gut-liver peptide hormone interactions.
Original Title:
Gastrointestinal peptide hormones in acute viral hepatitis.
Published In:
The Italian journal of gastroenterology, 28(2), 86-90 (1996)
Database ID:
RPEP-00356

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

A snapshot of a population at one point in time.

What do these levels mean? →

Frequently Asked Questions

What are gastrointestinal peptide hormones?

These are signaling molecules produced in the gut that regulate digestion, appetite, and metabolic functions. Examples include gastrin, cholecystokinin, secretin, and GLP-1. The liver helps regulate their levels by clearing them from the blood.

Why do liver disease patients have digestive problems?

When the liver is damaged, it can't properly regulate gut peptide hormones, leading to imbalances that cause nausea, appetite changes, and other digestive symptoms. This study showed these peptide imbalances normalize as the liver heals.

Read More on RethinkPeptides

Cite This Study

RPEP-00356·https://rethinkpeptides.com/research/RPEP-00356

APA

Budillon, G; Cuomo, R; Taccone, W; Panico, G; Pumpo, R; Iaquinto, G; Manzillo, G. (1996). Gastrointestinal peptide hormones in acute viral hepatitis.. The Italian journal of gastroenterology, 28(2), 86-90.

MLA

Budillon, G, et al. "Gastrointestinal peptide hormones in acute viral hepatitis.." The Italian journal of gastroenterology, 1996.

RethinkPeptides

RethinkPeptides Research Database. "Gastrointestinal peptide hormones in acute viral hepatitis." RPEP-00356. Retrieved from https://rethinkpeptides.com/research/budillon-1996-gastrointestinal-peptide-hormones-in

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.